Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
about
Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies.Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of PreeclampsiaSystematic Review of Micro-RNA Expression in Pre-Eclampsia Identifies a Number of Common Pathways Associated with the DiseasePravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).TH17- and IL-17- mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsiaPre-eclampsia part 2: prediction, prevention and management.Prediction and prevention of hypertensive disorders of pregnancy.Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study.Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study.sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).Preeclampsia and superimposed preeclampsia: The same disease? The role of angiogenic biomarkers.Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.
P2860
Q35567911-99B8BD90-6865-4B16-BAFF-68E26E56C1DDQ35813842-C8762A82-D403-4A08-9ED6-2E6B756E2BF0Q36104833-8A7F1EF0-6313-40C4-859A-5FD76141575FQ36455584-D3E1E31E-4D19-41D7-A2D6-06EF7BA81D58Q37385038-DF2964B2-382F-41C5-ABBC-619DAC8FBFC9Q38227251-B1715161-30F4-4FAA-822C-67583B7386A9Q38930161-1B627390-5CE1-4D65-BE06-F8082EC05B68Q39376655-D2CD1067-D0CD-44F0-8754-98BF3FCCACC6Q40367971-52304E86-1DB9-42EF-A015-1385525EB3F2Q41033848-C73C05A1-7606-46C3-9769-3FA2431DD09AQ49312791-DCA0B3BC-EEE6-45F8-B9F4-08E7E5E3CE68Q50180201-B735EAAC-B96B-471B-9A04-6C1E6B7D06ACQ54161406-973CA6C1-2FF3-400B-89FA-1E38BA7B69ECQ54211349-4423F224-502F-47A9-9978-F5BA8DE863B6Q55004295-269F4BB2-8299-4CD5-AAE2-CDBBBC211EAD
P2860
Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
@en
Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
@nl
type
label
Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
@en
Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
@nl
prefLabel
Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
@en
Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
@nl
P2093
P2860
P1476
Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
@en
P2093
Laura Robidoux
Melissa Moore
Sharon E Maynard
Susanne Bathgate
Sybil L Crawford
Tiffany A Moore Simas
P2860
P304
P356
10.3109/14767058.2013.847415
P577
2013-10-29T00:00:00Z